Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernia, Ventral | 9 | 2018 | 21 | 1.650 |
Why?
|
| Surgical Mesh | 11 | 2014 | 24 | 1.500 |
Why?
|
| Herniorrhaphy | 9 | 2018 | 36 | 1.410 |
Why?
|
| Postoperative Complications | 20 | 2018 | 916 | 1.160 |
Why?
|
| Hernia, Inguinal | 7 | 2016 | 21 | 1.150 |
Why?
|
| Obesity, Morbid | 2 | 2017 | 105 | 0.970 |
Why?
|
| Adenocarcinoma | 6 | 2016 | 137 | 0.930 |
Why?
|
| Laparoscopy | 13 | 2016 | 185 | 0.910 |
Why?
|
| Esophageal Neoplasms | 7 | 2002 | 50 | 0.830 |
Why?
|
| Stomach Neoplasms | 3 | 2016 | 34 | 0.680 |
Why?
|
| General Surgery | 4 | 2015 | 54 | 0.590 |
Why?
|
| Middle Aged | 42 | 2018 | 8923 | 0.550 |
Why?
|
| Cholecystectomy, Laparoscopic | 7 | 2015 | 20 | 0.540 |
Why?
|
| Gastroplasty | 1 | 2016 | 27 | 0.520 |
Why?
|
| Aged | 31 | 2018 | 8997 | 0.500 |
Why?
|
| Clinical Clerkship | 3 | 2013 | 30 | 0.490 |
Why?
|
| Male | 45 | 2020 | 14772 | 0.490 |
Why?
|
| Gastric Bypass | 1 | 2016 | 69 | 0.480 |
Why?
|
| Carcinoma | 3 | 2016 | 67 | 0.470 |
Why?
|
| Treatment Outcome | 22 | 2018 | 3485 | 0.450 |
Why?
|
| Humans | 60 | 2020 | 27074 | 0.440 |
Why?
|
| Adult | 30 | 2018 | 7831 | 0.430 |
Why?
|
| Educational Measurement | 3 | 2015 | 57 | 0.430 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2003 | 24 | 0.420 |
Why?
|
| Recurrence | 10 | 2017 | 310 | 0.420 |
Why?
|
| Quality Improvement | 4 | 2014 | 138 | 0.410 |
Why?
|
| Female | 42 | 2018 | 15213 | 0.410 |
Why?
|
| Retrospective Studies | 25 | 2018 | 3538 | 0.390 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 58 | 0.390 |
Why?
|
| Hepatectomy | 6 | 2015 | 61 | 0.390 |
Why?
|
| Liver Neoplasms | 5 | 2000 | 102 | 0.370 |
Why?
|
| Esophagectomy | 5 | 2002 | 23 | 0.370 |
Why?
|
| Colectomy | 3 | 2016 | 20 | 0.360 |
Why?
|
| Curriculum | 2 | 2003 | 138 | 0.360 |
Why?
|
| Polytetrafluoroethylene | 2 | 2003 | 5 | 0.350 |
Why?
|
| Pancreatic Neoplasms | 5 | 2013 | 93 | 0.330 |
Why?
|
| Aged, 80 and over | 13 | 2017 | 4777 | 0.290 |
Why?
|
| Students, Medical | 2 | 2013 | 56 | 0.280 |
Why?
|
| Risk Factors | 9 | 2018 | 2302 | 0.270 |
Why?
|
| Ambulatory Surgical Procedures | 3 | 2007 | 75 | 0.260 |
Why?
|
| Survival Rate | 9 | 2015 | 342 | 0.250 |
Why?
|
| Prospective Studies | 9 | 2014 | 1778 | 0.250 |
Why?
|
| Smoking | 2 | 2016 | 176 | 0.240 |
Why?
|
| Hernia, Hiatal | 2 | 2014 | 13 | 0.220 |
Why?
|
| Polypropylenes | 1 | 2003 | 1 | 0.210 |
Why?
|
| Prognosis | 6 | 2017 | 785 | 0.200 |
Why?
|
| Gastrectomy | 3 | 2015 | 30 | 0.200 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 1792 | 0.200 |
Why?
|
| Pancreaticoduodenectomy | 3 | 2013 | 10 | 0.200 |
Why?
|
| Cholangiography | 4 | 2015 | 7 | 0.200 |
Why?
|
| Ultrasonography | 4 | 2020 | 227 | 0.200 |
Why?
|
| Colorectal Neoplasms | 4 | 1997 | 110 | 0.190 |
Why?
|
| Laparotomy | 3 | 2020 | 18 | 0.190 |
Why?
|
| Hernia, Femoral | 1 | 2001 | 1 | 0.180 |
Why?
|
| United States | 9 | 2016 | 2035 | 0.180 |
Why?
|
| Mesenteric Cyst | 1 | 2020 | 3 | 0.170 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2000 | 7 | 0.170 |
Why?
|
| Lymphokines | 1 | 2000 | 10 | 0.170 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 11 | 0.170 |
Why?
|
| Early Diagnosis | 1 | 2020 | 57 | 0.170 |
Why?
|
| Elective Surgical Procedures | 2 | 2017 | 37 | 0.170 |
Why?
|
| Neovascularization, Pathologic | 1 | 2000 | 37 | 0.170 |
Why?
|
| Peritoneum | 2 | 2003 | 15 | 0.170 |
Why?
|
| Adolescent | 6 | 2007 | 2172 | 0.170 |
Why?
|
| Pneumonia | 2 | 2016 | 67 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1997 | 172 | 0.160 |
Why?
|
| Suture Techniques | 3 | 2007 | 157 | 0.160 |
Why?
|
| Surgical Wound Infection | 3 | 2016 | 86 | 0.150 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2018 | 4 | 0.150 |
Why?
|
| Cholelithiasis | 1 | 1998 | 6 | 0.150 |
Why?
|
| Compartment Syndromes | 1 | 2018 | 8 | 0.150 |
Why?
|
| Cholecystectomy | 3 | 2013 | 11 | 0.150 |
Why?
|
| Conservative Treatment | 1 | 2018 | 20 | 0.150 |
Why?
|
| Gallstones | 1 | 1998 | 8 | 0.150 |
Why?
|
| Biomarkers, Tumor | 1 | 2000 | 205 | 0.150 |
Why?
|
| Liver | 2 | 1997 | 145 | 0.140 |
Why?
|
| Survival Analysis | 6 | 2015 | 257 | 0.140 |
Why?
|
| Lipoma | 1 | 2017 | 6 | 0.140 |
Why?
|
| Myoepithelioma | 1 | 2017 | 4 | 0.140 |
Why?
|
| Internship and Residency | 3 | 2015 | 211 | 0.140 |
Why?
|
| Analysis of Variance | 3 | 2003 | 260 | 0.140 |
Why?
|
| Databases, Factual | 5 | 2016 | 347 | 0.140 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1996 | 3 | 0.130 |
Why?
|
| Trachea | 1 | 1997 | 46 | 0.130 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2017 | 54 | 0.130 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 7 | 0.130 |
Why?
|
| Enterostomy | 1 | 2016 | 5 | 0.130 |
Why?
|
| Portal Vein | 1 | 1996 | 46 | 0.130 |
Why?
|
| Prostheses and Implants | 1 | 1997 | 154 | 0.130 |
Why?
|
| Thrombosis | 1 | 1996 | 54 | 0.120 |
Why?
|
| Certification | 1 | 2015 | 24 | 0.120 |
Why?
|
| Radiation Tolerance | 1 | 1995 | 6 | 0.120 |
Why?
|
| Fundoplication | 2 | 2013 | 22 | 0.120 |
Why?
|
| Organs at Risk | 1 | 2015 | 7 | 0.120 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 8 | 0.120 |
Why?
|
| Hospital Costs | 1 | 1996 | 59 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2015 | 27 | 0.120 |
Why?
|
| Radiation Oncology | 1 | 2015 | 14 | 0.120 |
Why?
|
| Liver Regeneration | 1 | 1995 | 24 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 72 | 0.120 |
Why?
|
| Gallbladder Neoplasms | 1 | 2015 | 6 | 0.120 |
Why?
|
| Neoplasm Staging | 5 | 2015 | 363 | 0.120 |
Why?
|
| Logistic Models | 4 | 2016 | 395 | 0.120 |
Why?
|
| Clinical Competence | 3 | 2013 | 206 | 0.120 |
Why?
|
| Esophagus | 2 | 2012 | 63 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2017 | 458 | 0.120 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 51 | 0.120 |
Why?
|
| Appendectomy | 1 | 2014 | 14 | 0.120 |
Why?
|
| Safety | 2 | 2007 | 37 | 0.120 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 16 | 0.120 |
Why?
|
| Appendicitis | 1 | 2014 | 14 | 0.120 |
Why?
|
| Lymphoma | 1 | 2014 | 35 | 0.120 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 37 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 111 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 879 | 0.110 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 329 | 0.110 |
Why?
|
| Biliary Dyskinesia | 1 | 2013 | 3 | 0.110 |
Why?
|
| Pain, Postoperative | 3 | 2013 | 317 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2014 | 30 | 0.110 |
Why?
|
| Cholestasis | 1 | 1993 | 8 | 0.110 |
Why?
|
| Specialties, Surgical | 1 | 2013 | 3 | 0.110 |
Why?
|
| Surgical Procedures, Operative | 1 | 2013 | 29 | 0.110 |
Why?
|
| Gallbladder Diseases | 1 | 2013 | 3 | 0.110 |
Why?
|
| Duodenal Neoplasms | 1 | 2013 | 4 | 0.110 |
Why?
|
| Length of Stay | 5 | 2014 | 313 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 261 | 0.110 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2013 | 40 | 0.100 |
Why?
|
| Operative Time | 4 | 2014 | 91 | 0.100 |
Why?
|
| Abdominal Wall | 1 | 2013 | 7 | 0.100 |
Why?
|
| Stents | 1 | 1993 | 82 | 0.100 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2013 | 39 | 0.100 |
Why?
|
| Sepsis | 1 | 2014 | 113 | 0.100 |
Why?
|
| Sarcoma | 1 | 2015 | 147 | 0.100 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 77 | 0.100 |
Why?
|
| Kidney | 1 | 2013 | 153 | 0.100 |
Why?
|
| Prosthesis Implantation | 2 | 2013 | 26 | 0.100 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 317 | 0.100 |
Why?
|
| Esophageal Achalasia | 1 | 2012 | 18 | 0.100 |
Why?
|
| Time Factors | 4 | 2014 | 1433 | 0.090 |
Why?
|
| Morbidity | 3 | 2014 | 54 | 0.090 |
Why?
|
| Lymph Node Excision | 2 | 2015 | 27 | 0.080 |
Why?
|
| Reoperation | 5 | 2016 | 925 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2013 | 120 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 348 | 0.070 |
Why?
|
| Hernia, Abdominal | 1 | 2007 | 1 | 0.070 |
Why?
|
| Polyurethanes | 1 | 2007 | 7 | 0.070 |
Why?
|
| Omentum | 1 | 2007 | 7 | 0.070 |
Why?
|
| Chicago | 2 | 2001 | 949 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2000 | 125 | 0.070 |
Why?
|
| Child | 3 | 2001 | 1295 | 0.060 |
Why?
|
| Age Factors | 2 | 2016 | 766 | 0.060 |
Why?
|
| Sutures | 2 | 2003 | 53 | 0.060 |
Why?
|
| Anastomosis, Surgical | 2 | 2016 | 29 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2007 | 482 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 683 | 0.060 |
Why?
|
| Algorithms | 2 | 2015 | 350 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1368 | 0.050 |
Why?
|
| Comorbidity | 2 | 2016 | 481 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2014 | 313 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2002 | 42 | 0.050 |
Why?
|
| Disease-Free Survival | 2 | 2000 | 174 | 0.050 |
Why?
|
| Probability | 1 | 2002 | 88 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2002 | 94 | 0.050 |
Why?
|
| Workload | 1 | 2001 | 29 | 0.050 |
Why?
|
| Models, Educational | 1 | 2001 | 25 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2017 | 624 | 0.040 |
Why?
|
| Bile | 1 | 2020 | 6 | 0.040 |
Why?
|
| Intraoperative Care | 2 | 1998 | 41 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 1144 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2000 | 10 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 15 | 0.040 |
Why?
|
| Barrett Esophagus | 1 | 2000 | 16 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2000 | 75 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2000 | 93 | 0.040 |
Why?
|
| Endosonography | 1 | 1999 | 10 | 0.040 |
Why?
|
| Infant | 1 | 2001 | 564 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2001 | 641 | 0.040 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 1999 | 4 | 0.040 |
Why?
|
| Patient Selection | 1 | 2000 | 194 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2000 | 206 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1998 | 7 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 1998 | 20 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2020 | 642 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 1997 | 300 | 0.040 |
Why?
|
| Bronchial Neoplasms | 1 | 1997 | 5 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2017 | 13 | 0.040 |
Why?
|
| Groin | 1 | 2017 | 5 | 0.040 |
Why?
|
| Thigh | 1 | 2017 | 30 | 0.040 |
Why?
|
| Pilot Projects | 2 | 1997 | 420 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 49 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 1997 | 94 | 0.030 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 36 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 105 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 474 | 0.030 |
Why?
|
| Tobacco Smoking | 1 | 2016 | 5 | 0.030 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2016 | 6 | 0.030 |
Why?
|
| Intestinal Polyps | 1 | 1996 | 1 | 0.030 |
Why?
|
| Sigmoid Neoplasms | 1 | 1996 | 1 | 0.030 |
Why?
|
| Mesenteric Veins | 1 | 1996 | 2 | 0.030 |
Why?
|
| Cryosurgery | 1 | 1997 | 24 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 2016 | 16 | 0.030 |
Why?
|
| Rectal Neoplasms | 1 | 1996 | 14 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 366 | 0.030 |
Why?
|
| Cost Savings | 1 | 1996 | 32 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 49 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1995 | 1 | 0.030 |
Why?
|
| Bilirubin | 1 | 1995 | 11 | 0.030 |
Why?
|
| Intestines | 1 | 2016 | 80 | 0.030 |
Why?
|
| Cardia | 1 | 1995 | 3 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 1996 | 123 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 1995 | 14 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 1995 | 15 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 127 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 1995 | 107 | 0.030 |
Why?
|
| Random Allocation | 1 | 1995 | 124 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 96 | 0.030 |
Why?
|
| Hypertension | 1 | 2016 | 192 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 69 | 0.030 |
Why?
|
| Consensus | 1 | 2015 | 87 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 464 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 332 | 0.030 |
Why?
|
| Radiography | 1 | 1996 | 619 | 0.030 |
Why?
|
| Jejunum | 1 | 1994 | 10 | 0.030 |
Why?
|
| Surgical Stapling | 1 | 1994 | 5 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1994 | 23 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 145 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2015 | 130 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2014 | 67 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 250 | 0.030 |
Why?
|
| Digestive System Neoplasms | 1 | 1993 | 5 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 1999 | 383 | 0.030 |
Why?
|
| Rats | 1 | 1995 | 664 | 0.030 |
Why?
|
| Wound Healing | 1 | 2014 | 153 | 0.030 |
Why?
|
| Ileus | 1 | 2013 | 3 | 0.030 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2013 | 9 | 0.030 |
Why?
|
| Seroma | 1 | 2013 | 4 | 0.030 |
Why?
|
| Device Removal | 1 | 2013 | 85 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 1995 | 599 | 0.020 |
Why?
|
| Intraoperative Period | 3 | 1997 | 24 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 1999 | 457 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 587 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1890 | 0.020 |
Why?
|
| Quality of Life | 1 | 2013 | 629 | 0.020 |
Why?
|
| Ischemia | 1 | 2007 | 24 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2007 | 25 | 0.020 |
Why?
|
| Blood Loss, Surgical | 2 | 1999 | 56 | 0.020 |
Why?
|
| Animals | 1 | 1995 | 3642 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2007 | 490 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2002 | 21 | 0.010 |
Why?
|
| Medical Records | 1 | 2002 | 33 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2002 | 415 | 0.010 |
Why?
|
| Cystadenocarcinoma | 1 | 1999 | 1 | 0.010 |
Why?
|
| Cystadenoma | 1 | 1999 | 1 | 0.010 |
Why?
|
| Retroperitoneal Space | 1 | 1999 | 8 | 0.010 |
Why?
|
| Orthopedic Fixation Devices | 1 | 1999 | 19 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1997 | 46 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1997 | 99 | 0.010 |
Why?
|
| Cisplatin | 1 | 1997 | 58 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1997 | 220 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1997 | 245 | 0.010 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 1994 | 7 | 0.010 |
Why?
|
| Esophagogastric Junction | 1 | 1994 | 13 | 0.010 |
Why?
|
| Bile Ducts | 1 | 1993 | 4 | 0.010 |
Why?
|
| Puerto Rico | 1 | 1993 | 12 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 91 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1993 | 63 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1997 | 1112 | 0.010 |
Why?
|